Ovarian Cancer Stage III
Oncology
Prevalence
24.0 / 100K
Incidence
10.6 / 100K/yr
0 drugs in development·0 companies·2 clinical trials
Frequently asked questions
How many clinical trials target Ovarian Cancer Stage III?
There are 2 clinical trials targeting Ovarian Cancer Stage III tracked by BioSniper.
What is the prevalence of Ovarian Cancer Stage III?
The estimated prevalence of Ovarian Cancer Stage III is approximately 24.0 per 100,000 population.
Deep-dive into Ovarian Cancer Stage III
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis